• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON MEDICAL (SINGAPORE) BD VENFLON¿ PRO SAFETY IV CANNULA WITH INSTAFLASH¿; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON MEDICAL (SINGAPORE) BD VENFLON¿ PRO SAFETY IV CANNULA WITH INSTAFLASH¿; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 393280
Device Problem Break (1069)
Patient Problems Pain (1994); Foreign Body In Patient (2687)
Event Date 01/12/2023
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the bd venflon¿ pro safety iv cannula with instaflash¿ broke from the hub and remained in the patient's vein.The patient received an urgent surgical consultation followed by an ultrasound of the affected area.The surgeon was able to locate the foreign body under local anesthesia and remove it.The following information was provided by the initial reporter: "on (b)(6) 2023, in the evening, the patient was inserted a peripheral puncture, and the prescribed medications were administered.The patient reported no abnormalities, and the peripheral puncture was active (left hand wrist).In the morning (b)(6) 2023, during the morning administration of the medication, the patient reported slight pain in the venflon area.The nurse removed the insertion and observed that the plastic part of the venflon stayed in the vein.This fact was immediately reported, and corrective action was taken.No immediate consequences for the patient.The patient was given an urgent surgical consultation.An ultrasound of the vessel was performed.By palpation, the surgeon felt the foreign body and under local anesthesia removed the foreign body from the vein.".
 
Manufacturer Narrative
H.6.Investigation summary: no photos or samples were received by our quality team for evaluation therefore the failure mode could not be verified.A review of the internal manufacturing device records and raw material history files for the reported lot number was performed and no recorded quality problems or rejections to this incident were found.Based on the quality team's investigation, the root cause of this incident cannot be determined.Examination of the product involved may provide clarification as to the cause for the reported failure.Complaints received for this product and condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business regularly reviews the collected data for identification of emerging trends.
 
Event Description
It was reported that the bd venflon¿ pro safety iv cannula with instaflash¿ broke from the hub and remained in the patient's vein.The patient received an urgent surgical consultation followed by an ultrasound of the affected area.The surgeon was able to locate the foreign body under local anesthesia and remove it.The following information was provided by the initial reporter: "on (b)(6) 2023, in the evening, the patient was inserted a peripheral puncture, and the prescribed medications were administered.The patient reported no abnormalities, and the peripheral puncture was active (left hand wrist).In the morning ((b)(6) 2023), during the morning administration of the medication, the patient reported slight pain in the venflon area.The nurse removed the insertion and observed that the plastic part of the venflon stayed in the vein.This fact was immediately reported, and corrective action was taken.No immediate consequences for the patient.The patient was given an urgent surgical consultation.An ultrasound of the vessel was performed.By palpation, the surgeon felt the foreign body and under local anesthesia removed the foreign body from the vein.".
 
Manufacturer Narrative
The following fields were updated due to additional information: d10: device available for eval yes, d10: returned to manufacturer on: 23-may-2023.Investigation summary: our quality engineer inspected the 1 sample submitted for evaluation.The reported issues of irritation / inflammation, leakage and catheter broke / separated after placement were confirmed upon inspection of the sample.Analysis of the sample showed that multiple cuts and scratches were found at the cannula hub tip near the catheter.A jagged cut was observed on the broken edge of the used sample.A partial cut on the catheter near the cannula hub tip was also observed.We reviewed our manufacturing processes and there were no portions of the manufacturing process that could have resulted in the damages observed.A potential root cause could be related to the application of the device.If the device was used around sharp objects such as using scissor to open the packaging, there is a chance the damages observed could occur.However, we cannot confirm this root cause since we cannot confirm how the product was used.A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.Production records were reviewed, and this batch meets our manufacturing specification requirements.
 
Event Description
It was reported that the bd venflon¿ pro safety iv cannula with instaflash¿ broke from the hub and remained in the patient's vein.The patient received an urgent surgical consultation followed by an ultrasound of the affected area.The surgeon was able to locate the foreign body under local anesthesia and remove it.The following information was provided by the initial reporter: "on (b)(6) 2023, in the evening, the patient was inserted a peripheral puncture, and the prescribed medications were administered.The patient reported no abnormalities, and the peripheral puncture was active (left hand wrist).In the morning (b)(6) 2023), during the morning administration of the medication, the patient reported slight pain in the venflon area.The nurse removed the insertion and observed that the plastic part of the venflon stayed in the vein.This fact was immediately reported, and corrective action was taken.No immediate consequences for the patient.The patient was given an urgent surgical consultation.An ultrasound of the vessel was performed.By palpation, the surgeon felt the foreign body and under local anesthesia removed the foreign body from the vein.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD VENFLON¿ PRO SAFETY IV CANNULA WITH INSTAFLASH¿
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON MEDICAL (SINGAPORE)
30 tuas avenue 2
singapore
Manufacturer (Section G)
BECTON DICKINSON MEDICAL (SINGAPORE)
30 tuas avenue 2
singapore
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key16288086
MDR Text Key308702587
Report Number8041187-2023-00042
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
Reporter Country CodePL
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 06/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/02/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number393280
Device Lot Number2233029
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/13/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/21/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-